Spain· ES:1211555001
GAVRETO 100 MG CAPSULAS DURAS
A medicinal product containing pralsetinib, registered in Spain by Blueprint Medicines (Netherlands) B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- pralsetinib
- Manufacturer
- Blueprint Medicines (Netherlands) B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pralsetinib in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGavretoRigel Pharmaceuticals, Inc.
- FinlandGavretoBlueprint Medicines Netherlands B.V.
- FranceGAVRETO 100 mg, géluleBLUEPRINT MEDICINES (PAYS-BAS))
- BelgiumGavreto 100 mgBlueprint Medicines (Netherlands)
- NorwayGavretoRoche
- PolandGavretoRoche Registration GmbH
- United KingdomGavreto 100mg capsulesBlueprint Medicines (UK) Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3ae65d7-17ea-46bf-b7cf-b3e36d6156bb GET /v1/drugs/c3ae65d7-17ea-46bf-b7cf-b3e36d6156bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1639041725000,\"rev\":1732778941000}",
"nregistro": "1211555001",
"substance": "pralsetinib"
}See everything about pralsetinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.